Delursan and blood alkaline phosphatase increased Patient Reports February 13, 2012

Delursan Side Effects Report #5808083-9
Delursan side effect was reported by a Consumer or non-health professional from FRANCE on June 26, 2008. Female patient, 56 years of age, was diagnosed with cholestasis, sarcoidosis and was treated with Delursan. After drug was administered, patient experienced the following side effects: amenorrhoea, angiotensin converting enzyme increased, blood alkaline phosphatase increased, blood creatinine decreased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, haemoglobin decreased, hepatosplenomegaly, hyperproteinaemia. Delursan dosage: 500 MG (DELURSAN) ORAL. During the same period patient was treated with URSOLVAN, RIFAMPICINE, ISONIAZIDE, PYRAZINAMIDE, RIFINAH. Patient was hospitalized. Patient recovered.